Coloproctology pp 217-228 | Cite as

Other Colitides

Chapter
Part of the European Manual of Medicine book series (EUROMANUAL)

Abstract

Colitis other than ulcerative colitis or Crohn’s disease affects a large group of patients. Etiology is multifactorial and includes infection, hyperosmolar formula feeding, a lack of breast milk, ischemia and reperfusion injury, Clostridium difficile, and viral and parasitic agents. The main symptoms are diarrhea; leukocytosis; fever; abdominal pain or cramping; bloody, mucoid, green, foul-smelling stools; the urge to defecate; and others such as dehydration, electrolyte disturbances, nausea, vomiting, malaise, anorexia, hypoalbuminemia, and anasarca. Diagnostic procedures include laboratory studies, endoscopy, plain abdominal radiography, computed tomography, and histology. Therapy depends of the exact diagnosis and may include conservative treatment; antibiotics causing the condition should be stopped and the patient should be rehydrated and given metronidazole/vancomycin). Surgery is required in rare cases to treat infections that worsen or do not respond to conservative treatment, or when there are any complications. Various approaches can be used, including early subtotal colectomy, colectomy, colostomy, ileostomy, and resection of the diseased bowel.

Keywords

Colitis Necrotizing enterocolitis Ischemic Pseudomembranous Infectious Microscopic 

References

  1. 1.
    Fagenholz PJ, de Moya MA. Acute inflammatory surgical disease. Surg Clin North Am. 2014;94(1):1–30. doi: 10.1016/j.suc.2013.10.008.CrossRefPubMedGoogle Scholar
  2. 2.
    Moldovan R, Vlad N, Curca G, Borcea M, Ferariu D, Dimofte G, Tarcoveanu E. Total necrotizing colitis proximal to obstructive left colon cancer: case report and literature review. Chirurgia (Bucur). 2013;108(3):396–9.Google Scholar
  3. 3.
    Bode L, Jantscher-Krenn E. Structure-function relationships of human milk oligosaccharides. Adv Nutr. 2012;3(3):383–91.CrossRefGoogle Scholar
  4. 4.
    Sherid M, Ehrenpreis ED. Types of colitis based on histology. Dis Mon. 2011;57(9):457–89.CrossRefPubMedGoogle Scholar
  5. 5.
    Andres LA, Ford RD, Wilcox RM. Necrotizing colitis caused by systemic aspergillosis in a burn patient. J Burn Care Res. 2007;28(6):918–21.CrossRefPubMedGoogle Scholar
  6. 6.
    McDonald EG, Lee TC. Treatment for Clostridium difficile infection in adults. JAMA. 2015;313(19):1974–5.CrossRefPubMedGoogle Scholar
  7. 7.
    Aldrete Sdel M, Magee MJ, Friedman-Moraco RJ, Chan AW, Banks GG, Burd EM, Kraft CS. Characteristics and antibiotic use associated with short-term risk of clostridium difficile infection among hospitalized patients. Am J Clin Pathol. 2015;143(6):895–900.CrossRefPubMedGoogle Scholar
  8. 8.
    Bagdasarian N, Rao K, Malani PN. Diagnosis and treatment of Clostridium difficile in adults: a systematic review. JAMA. 2015;313(4):398–408.CrossRefPubMedGoogle Scholar
  9. 9.
    Leffler DA, Lamont JT. Clostridium difficile infection. N Engl J Med. 2015;372(16):1539–48.CrossRefPubMedGoogle Scholar
  10. 10.
    Farooq PD, Urrunaga NH, Tang DM, von Rosenvinge EC. Pseudomembranous colitis. Dis Mon. 2015;61(5):181–206.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Costello SP, Chung A, Andrews JM, Fraser RJ. Fecal microbiota transplant for Clostridium difficile colitis-induced toxic megacolon. Am J Gastroenterol. 2015;110(5):775–7.CrossRefPubMedGoogle Scholar
  12. 12.
    Marcos LA, Gersh A, Blanchard K, Foil S, Mallini B, Farrell SE, Kahler RJ. Fecal transplantation to treat initial severe Clostridium difficile infection with sepsis. Miss State Med Assoc. 2015;56(2):38–40.Google Scholar
  13. 13.
    Cammarota G, Masucci L, Ianiro G, Bibbò S, Dinoi G, Costamagna G, Sanguinetti M, Gasbarrini A. Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. Aliment Pharmacol Ther. 2015;41(9):835–438.CrossRefPubMedGoogle Scholar
  14. 14.
    FitzGerald JF, Hernandez Iii LO. Ischemic colitis. Clin Colon Rectal Surg. 2015;28(2):93–8.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Mosińska P, Fichna J. Ischemic colitis: current diagnosis and treatment. Curr Drug Targets. 2015;16(3):209–18.CrossRefPubMedGoogle Scholar
  16. 16.
    Hines DM, McGuiness CB, Schlienger RG, Makin C. Incidence of ischemic colitis in treated, commercially insured hypertensive adults: a cohort study of US health claims data. Am J Cardiovasc Drugs. 2015;15(2):135–49.CrossRefPubMedGoogle Scholar
  17. 17.
    Zollner-Schwetz I, Herzog KA, Feierl G, Leitner E, Schneditz G, Sprenger H, Prattes J, Petritsch W, Wenzl H, Kump P, Gorkiewicz G, Zechner E, Högenauer C. The toxin-producing Pathobiont Klebsiella oxytoca is not associated with flares of inflammatory bowel diseases. Dig Dis Sci. 2015;60:3393–8.CrossRefPubMedGoogle Scholar
  18. 18.
    Horiki N, Furukawa K, Kitade T, Sakuno T, Katsurahara M, Harada T, Tano S, Yamada R, Hamada Y, Inoue H, Tanaka K, Gabazza EC, Ishii N, Fukuda K, Omata F, Fujita Y, Tachibana H, Takei Y. Endoscopic findings and lesion distribution in amebic colitis. J Infect Chemother. 2015;21(6):444–8.CrossRefPubMedGoogle Scholar
  19. 19.
    Korman T. Diagnosis and management of Clostridium difficile infection. Semin Respir Crit Care Med. 2015;36(1):31–43.CrossRefPubMedGoogle Scholar
  20. 20.
    Macaigne G. Microscopic colitis. Rev Prat. 2015;65(3):307–11.PubMedGoogle Scholar
  21. 21.
    Bouma G, Münch A. Microscopic colitis. Dig Dis. 2015;33(2):208–14.CrossRefPubMedGoogle Scholar
  22. 22.
    Plastaras L, Vuitton L, Badet N, Koch S, Di Martino V, Delabrousse E. Acute colitis: differential diagnosis using multidetector CT. Clin Radiol. 2015;70(3):262–9.CrossRefPubMedGoogle Scholar
  23. 23.
    Assa A, Vong L, Pinnell LJ, Avitzur N, Johnson-Henry KC, Sherman PM. Vitamin D deficiency promotes epithelial barrier dysfunction and intestinal inflammation. J Infect Dis. 2014;210(8):1296–305.CrossRefPubMedGoogle Scholar
  24. 24.
    Langner C, Aust D, Ensari A, Villanacci V, Becheanu G, Miehlke S, Geboes K, Münch A, Working Group of Digestive Diseases of the European Society of Pathology (ESP), European Microscopic Colitis Group (EMCG). Histology of microscopic colitis-review with a practical approach for pathologists. Histopathology. 2015;66(5):613–26.CrossRefPubMedGoogle Scholar
  25. 25.
    Ohlsson B. New insights and challenges in microscopic colitis. Ther Adv Gastroenterol. 2015;8(1):37–47.CrossRefGoogle Scholar
  26. 26.
    Farrukh A, Mayberry JF. Microscopic colitis: a review. Colorectal Dis. 2014;16(12):957–64.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  1. 1.Department of General and Colorectal SurgeryUniversity HospitalLodzPoland

Personalised recommendations